SEC Comment Letter 0000000000-24-011449 to PaxMedica, Inc. (PXMD) (CIK 0001811623)
PaxMedica, Inc. (PXMD) (CIK 0001811623)
Date: Oct. 9, 2024 · CIK: 0001811623 · Accession: 0000000000-24-011449
AI Filing Summary & Sentiment
File numbers found in text: 333-282488
Letter
October 9, 2024 Howard Weisman Chief Executive Officer PaxMedica, Inc. 101 Arch Street, 8th Floor Boston, MA 02110 Re:PaxMedica, Inc. Registration Statement on Form S-1 Filed October 3, 2024 File No. 333-282488 Dear Howard Weisman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Scot Foley, Esq.
Show Raw Text
October 9, 2024
Howard Weisman
Chief Executive Officer
PaxMedica, Inc.
101 Arch Street, 8th Floor
Boston, MA 02110
Re:PaxMedica, Inc.
Registration Statement on Form S-1
Filed October 3, 2024
File No. 333-282488
Dear Howard Weisman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Scot Foley, Esq.